A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy

A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy

Abstract Background In this study we aimed to identify a prognostic signature in BRCA1/2 mutations to predict disease progression and the efficiency of chemotherapy ovarian cancer (OV), the second most common cause of death from gynecologic cancer in women worldwide. Methods Univariate Cox proportio...

Full description

Bibliographic Details
Main Authors: Yinglian Pan, Li Ping Jia, Yuzhu Liu, Yiyu Han, Qian Li, Qin Zou, Zhongpei Zhang, Jin Huang, Qingchun Deng
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Journal of Ovarian Research
Subjects:
Ovarian cancer
Long non-coding RNA
Prognostic biomarker
Mutations
BRCA1/2 gene
Chemotherapy
Online Access:http://link.springer.com/article/10.1186/s13048-020-00712-w

Internet

http://link.springer.com/article/10.1186/s13048-020-00712-w

Similar Items